From: Clinical and molecular characterization of 112 single-center patients with Neurofibromatosis type 1
Age distribution at diagnosis
0–1 year
2–4 years
5–18 years
19–30 years
31–60 years
6 (5%)
11 (10%)
78 (70%)
9 (8%)
8 (7%)